Evidence map›Paper›PMID 33188303›Full record

ReviewNature reviews. Immunology2021

Determining the effector response to cell death.

Carla V Rothlin, Thomas D Hille, Sourav Ghosh

Abstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Ferroptosis and tumor immunity.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Peripheral nerve injury reduces macrophage efferocytosis to facilitate neuropathic pain.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. CD73 Expression by CD4Immunology · 2025
    Article
  8. Regulation of inflammatory processes by caspases.Nature reviews. Molecular cell biology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Targeting ROS in cancer: rationale and strategies.Nature reviews. Drug discovery · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carla V Rothlin *Department of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA. carla.rothlin@yale.edu.ORCID http://orcid.org/0000-0002-5693-5572
Thomas D HilleDepartment of Mathematics, Yale University, New Haven, CT, USA.
Sourav Ghosh *Department of Pharmacology, School of Medicine, Yale University, New Haven, CT, USA. sourav.ghosh@yale.edu.ORCID http://orcid.org/0000-0001-5990-8708

Funding

TAM receptor tyrosine kinases in inflammatory boweldiseaseR01AI089824 · NIAID · YALE UNIVERSITY · PI ROTHLIN, CARLA · 2010 to 2018
$3.9M
An innate immune checkpoint in cancer immunotherapy.R01CA212376 · NCI · YALE UNIVERSITY · PI GHOSH, SOURAV, ROTHLIN, CARLA · 2017 to 2021
$3.1M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA212376NIAID NIH HHS R01 AI089824
6 · The paper itself

Abstract

Cell death occurs when a pathogen invades a host organism or the organism is subjected to sterile injury. Thus, cell death is often closely associated with the induction of an immune response. Furthermore, cell death can occur as a consequence of the immune response and precedes the tissue renewal and repair responses that are initiated by innate immune cells during resolution of an immune response. Beyond immunity, cell death is required for development, morphogenesis and homeostasis. How can such a ubiquitous event as cell death trigger such a wide range of context-specific effector responses? Dying cells are sensed by innate immune cells using specialized receptors and phagocytosed through a process termed efferocytosis. Here, we outline a general principle whereby signals within the dead cell as well as the environment are integrated by specific efferocytes to define the appropriate effector response.

Indexed as

AnimalsCell DeathCellular MicroenvironmentCytokinesHomeostasisHost-Pathogen InteractionsHumansImmunity, InnateMathematical ConceptsModels, ImmunologicalPhagocytesPhagocytosisSignal TransductionCytokines

Identifiers

PMID33188303
PMCPMC8102327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.